Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice
- 18 March 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 328 (3) , 800-807
- https://doi.org/10.1016/j.bbrc.2005.01.019
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002
- STAT-3 Activation Is Required for Normal G-CSF-Dependent Proliferation and Granulocytic DifferentiationImmunity, 2001
- Bone Resorption by OsteoclastsScience, 2000
- STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid HormoneJournal of Biological Chemistry, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- STATs and Gene RegulationScience, 1997
- Bone and haematopoietic defects in mice lacking c-fosNature, 1992
- The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor geneNature, 1990
- Purification and Characterization of Mouse Hematopoietic Stem CellsScience, 1988